Allurion Technologies (ALURD) Cash & Equivalents (2022 - 2026)
Allurion Technologies' (ALURD) quarterly Cash & Equivalents came in at $5.1 million in Q1 2026, down 75.23% YoY from $20.4 million in Q1 2025, and down 6.58% on a QoQ basis from $5.4 million in Q4 2025.
Allurion Technologies (ALURD) Cash & Equivalents (2022 - 2026) Analysis & Trends
Allurion Technologies (ALURD) has 5 years of Cash & Equivalents data on file, last reported at $5.1 million in Q1 2026.
- Quarterly Cash & Equivalents fell 75.23% year-over-year to $5.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.1 million (down 75.23% YoY) and the FY2025 annual result came in at $5.4 million, down 64.81% from the prior year.
- Cash & Equivalents declined to $5.1 million in Q1 2026, from $5.4 million in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $79.9 million in Q3 2023 to a low of $4.7 million in Q2 2023.
- A 5-year average of $21.0 million and a median of $15.4 million in 2024 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2023 — Cash & Equivalents soared 394.95% — and 2025, when it tumbled 78.59%.
- Tracing ALURD's Cash & Equivalents over 5 years: stood at $7.7 million in 2022, then soared by 394.95% to $38.0 million in 2023, then plunged by 59.57% to $15.4 million in 2024, then sank by 64.81% to $5.4 million in 2025, then slipped by 6.58% to $5.1 million in 2026.
- The last three Cash & Equivalents figures came in at $5.1 million (Q1 2026), $5.4 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Allurion Technologies | 49.18 Mn | 44.13 Mn | 1.23 Mn | 5.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.06 Mn |
| Dec 31, 2025 | 5.41 Mn |
| Sep 30, 2025 | 6.14 Mn |
| Jun 30, 2025 | 12.72 Mn |
| Mar 31, 2025 | 20.41 Mn |
| Dec 31, 2024 | 15.38 Mn |
| Sep 30, 2024 | 28.65 Mn |
| Jun 30, 2024 | 19.26 Mn |
| Mar 31, 2024 | 29.68 Mn |
| Dec 31, 2023 | 38.04 Mn |
| Sep 30, 2023 | 79.87 Mn |
| Jun 30, 2023 | 4.74 Mn |
| Dec 31, 2022 | 7.69 Mn |